Type of Care
- Substance Use Treatment
Facility Operation (e.g., Private, Public)
- Private for-profit organization
Payment/Insurance/Funding Accepted
- Cash or self-payment
Assessment/Pre-treatment
- Comprehensive substance use assessment
- Outreach to persons in the community
Screening & Testing
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for substance use
- STD testing
- Drug and alcohol oral fluid testing
Transitional Services
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Ancillary Services
- Social skills development
- Mentoring/peer support/consumer-run services
Service Settings (e.g., Outpatient, Residential, Inpatient, etc.)
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
Counseling Services and Education
- Individual counseling
- Group counseling
- Substance use education
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
Tobacco/Screening Services
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy
- Smoking permitted in designated area
Age Groups Accepted
- Adults
- Young adults
Gender Accepted
- Female
- Male
Exclusive Services
- All Clients in Opioid Treatment Program
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
External Opioid Medications Source
- Does not treat alcohol use disorder
Type of Opioid Treatment
- Buprenorphine maintenance
- Buprenorphine maintenance for predetermined time
- Prescribes buprenorphine
Pharmacotherapies
- Acamprosate (Campral®)
- Buprenorphine sub-dermal implant (Probuphine®)
- Buprenorphine with naloxone (Ex. Suboxone®)
- Buprenorphine (extended-release, injectable, for example, Sublocade®)
Treatment Approaches
- Cognitive behavioral therapy
- Motivational interviewing
- Relapse prevention
- Substance use counseling approach